SHIKIGAKU.Co.,Ltd. Logo

SHIKIGAKU.Co.,Ltd.

Drives organizational growth with a unique management theory for diverse corporate clients.

7049 | T

Overview

Corporate Details

ISIN(s):
N/A
LEI:
Country:
Japan
Address:
品川区大崎二丁目9番3号大崎ウエストシティビル1階
Sector:
Mining and quarrying
Industry:
Mining of non-ferrous metal ores

Description

SHIKIGAKU.Co.,Ltd. is a management consulting company that provides services based on its proprietary management theory, "Shikigaku." This theory is designed to facilitate long-term, continuous organizational growth by clarifying roles and responsibilities to eliminate inefficiencies and reduce employee turnover. The company offers consulting and hands-on support to a diverse range of corporate clients across various industries and sizes. In addition to its core consulting business, SHIKIGAKU operates a venture capital arm, as well as community management, sports, and entertainment businesses for individual consumers, applying its unique theoretical principles across all operations.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-06-02 08:34
Registration Form
確認書
Japanese 8.9 KB
2025-06-02 08:32
Annual Report
訂正有価証券報告書-第10期(2024/03/01-2025/02/28)
Japanese 892.2 KB
2025-05-29 08:31
Post-Annual General Meeting Information
臨時報告書
Japanese 23.5 KB
2025-05-29 08:31
Governance Information
内部統制報告書-第10期(2024/03/01-2025/05/28)
Japanese 24.2 KB
2025-05-29 08:30
Registration Form
確認書
Japanese 8.9 KB
2025-05-29 08:30
Registration Form
有価証券報告書-第10期(2024/03/01-2025/02/28)
Japanese 1.6 MB
2025-05-28 09:26
Major Shareholding Notification
訂正報告書(大量保有報告書・変更報告書)
Japanese 43.2 KB
2025-04-18 05:50
Major Shareholding Notification
変更報告書
Japanese 59.3 KB
2024-10-11 08:30
Interim Report
確認書
Japanese 9.0 KB
2024-10-11 08:30
Interim Report
半期報告書-第10期(2024/03/01-2025/02/28)
Japanese 250.4 KB
2024-07-23 08:30
Transaction in Own Shares
自己株券買付状況報告書(法24条の6第1項に基づくもの)
Japanese 25.0 KB
2024-07-10 08:30
Quarterly Report
四半期報告書-第10期第1四半期(2024/03/01-2024/05/31)
Japanese 179.8 KB
2024-07-10 08:30
Regulatory News Service
確認書
Japanese 9.0 KB
2024-07-08 08:40
Major Shareholding Notification
臨時報告書
Japanese 21.0 KB
2024-06-03 08:32
Registration Form
確認書
Japanese 8.9 KB

Automate Your Workflow. Get a real-time feed of all SHIKIGAKU.Co.,Ltd. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for SHIKIGAKU.Co.,Ltd. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
Lipidor AB Logo
Develops topical skin treatments by reformulating drugs with a lipid-based delivery platform.
Sweden LIPI
Mare Nostrum Logo
Comprehensive HR solutions provider for recruitment, temporary work, training, and wage portage.
France ALMAR
Marubeni Construction Material Lease Co.,Ltd. Logo
Leases and sells temporary steel materials and offers engineering for major construction projects.
Japan 9763
MATCHING SERVICE JAPAN CO.,LTD. Logo
Specialized recruitment firm connecting legal, finance, and accounting experts with top companies.
Japan 6539
Material Group inc. Logo
A professional services firm offering PR consulting, marketing, and brand strategy.
Japan 156A
Medesis Pharma S.A. Logo
Develops therapies for CNS disorders and radiation exposure via a drug delivery platform.
France ALMDP
Medicofarma Biotech Spolka Akcyjna Logo
A biotech R&D company developing innovative drugs and devices with a focus on oncology therapies.
Poland MDB
Develops biomarker-based precision therapies for oncology and other incurable diseases.
South Korea 235980
Medrx Co.,Ltd. Logo
Develops and licenses transdermal drug delivery systems for the pharmaceutical industry.
Japan 4586
Developing nanomedicines and drug delivery systems for oncology, hematology, and diagnostics.
Malaysia N/A

Talk to a Data Expert

Have a question? We'll get back to you promptly.